ClinicalTrials HQ

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Active, not recruiting · NCT06571045 · Registry updated 2026-09-30
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DMEDiabetic Macular Edema (DME)Active, not recruitingPhase 2 / Phase 32026-09-30NCT06571045

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
EyeBiotech Ltd.5

183 results · Page 1 of 8

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Abilene, TXAbileneUnited States2
Albury, AustraliaAlburyAustralia1
Amarillo, TXAmarilloUnited States1
Amarillo, TXAmarilloUnited States2
Ankara, TurkeyAnkaraTurkey (Türkiye)1
Ankara, TurkeyAnkaraTurkey (Türkiye)1
Arecibo, PRAreciboPuerto Rico1
Arlington, TXArlingtonUnited States2
Asheville, NCAshevilleUnited States2
Austin, TXAustinUnited States3
Bakersfield, CABakersfieldUnited States2
Balcova, TurkeyBalçovaTurkey (Türkiye)1
Barcelona, SpainBarcelonaSpain1
Barcelona, SpainBarcelonaSpain1
Barcelona, SpainBarcelonaSpain1
Barcelona, SpainBarcelonaSpain1
Barranquilla, ColombiaBarranquillaColombia1
Beaufort, SCBeaufortUnited States2
Beaumont, TXBeaumontUnited States1
Beer Yakov, IsraelBe’er Ya‘aqovIsrael1
Bellaire, TXBellaireUnited States4
Bethlehem, PABethlehemUnited States2
Bialystok, PolandBialystokPoland1
Bloomfield, NJBloomfieldUnited States3
Bogota, ColumbiaBogotáColombia1